The ASAM Review Course Spotlight Webinar Series (6 CME)

REVIEW COURSE ATTENDEES RECEIVE 25% OFF - 
Use the promo code located in your syllabus when checking out to take advantage of this special deal!

Looking to stay engaged and expand your ASAM Review Course experience? This six-webinar series will offer an additional, in-depth look at some of the most popular sessions from the ASAM Review Course in Addiction Medicine. 

Each webinar will be an hour long, with 30-45 minutes of lecture on the topic of the week and the rest saved for audience questions. Questions will be collected in advance from participants of the 2017 Review Course and as part of the webinar registration process – don’t miss your chance to ask the experts! 

Edwin A. Salsitz

MD, DFASAM

Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Assistant Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. 

Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings,and is a mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. 

Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.  Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.

Richard K. Ries

MD, DFASAM

Richard K. Ries, MD, is Professor of Psychiatry, and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle, Washington and Director of the Addiction Treatment services at Harborview Medical Center in downtown Seattle. Dr. Ries received his undergraduate degree from Stanford, medical degree from Northwestern Medical School and completed his psychiatric residency at the University of Washington, Seattle, where he was Chief Resident. Dr. Ries is board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine.   A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, he is on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health. He has published numerous articles and abstracts on topics related to treatment of persons with severe mental illness, with special emphasis on those with co-existing problems with alcohol or drugs, and was the chair and co-chair of TIPS 9 and 42 on Treatment of Persons with Co-occurring  Addiction and Mental Disorders published by the national Center of Substance Abuse Treatment (CSAT).  He is senior editor of  the key reference text:  Principles of Addiction Medicine (edition V, 2014), published by the American Society of Addiction Medicine, and a noted expert in the  field of Addictions.

Carla Marienfeld

MD

Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of California San Diego. Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid psychiatric conditions. She previously worked at a large outpatient addiction treatment program serving over 5000 patients. Her academic interests focus on implementation research and large-data health outcomes for patients with substance use disorders. She attended Baylor College of Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction. During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships. She completed a fellowship in Addiction Psychiatry at Yale. During residency and her early faculty years, she founded and led the Yale Global Mental Health Program. She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry. She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program and a new Addiction Psychiatry Fellowship.

Abigail J. Herron

DO, DFASAM

Abigail J. Herron, DO, is the Director of Psychiatry and the Director of the Fellowship in Addiction Medicine at the Institute for Family Health.  She is board certified in adult psychiatry, addiction psychiatry and addiction medicine, and is an Assistant Professor of Psychiatry at the Icahn School of Medicine at Mt. Sinai.  Dr. Herron is a fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine.  She graduated from Wesleyan University and the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.  Dr. Herron completed her psychiatry residency at St. Luke's and Roosevelt Hospitals, where she was also chief resident, and a clinical research fellowship in addiction psychiatry at Columbia University and the New York State Psychiatric Institute.  Her academic interests include integrated care, women’s health, and medical education.  She is the co-editor of the Addiction Casebook, and the editor-in-chief of ASAM’s Essentials of Addiction Medicine.  Dr. Herron is also in private practice in New York City. 

Sharon Stancliff

MD, FAAFP

Sharon Stancliff, M.D. is the Medical Director of the Harm Reduction Coalition She oversees SKOOP, which provides overdose prevention services both directly in New York City and through education and capacity building nationally and internationally. Dr. Stancliff also consults on drug related problems for the AIDS Institute, New York State Department of Health and for several international organizations. Dr. Stancliff graduated from the School of Medicine at University of California at Davis, did her Family Practice residency at the University of Arizona and completed the AIDS Institute-sponsored Nicolas Rango HIV Clinical Scholars Program at Beth Israel Medical Center in New York City. She is board certified in Family Medicine, a Fellow of the American Academy of Family Practice, and certified by the American Board of Addiction Medicine. She serves as secretary for the New York Society of Addiction Medicine.

Timothy Wiegand

MD, FACMT, FAACT, FASAM

Tim Wiegand MD, DABAM, FACMT, FAACT was trained in internal medicine and completed fellowship training in Medical Toxicology at the University of California, San Francisco in 2006. He was the Medical Director of the Rochester Poison Center until 2010. Dr Wiegand has been successful in developing a full time, bedside, medical toxicology consultation service and is very active in the practice of Addiction Medicine, having successfully completed his board certification recently. In addition to his primary appointment as Associate Professor of Emergency Medicine at the University of Rochester School of Medicine & Dentistry in Rochester, NY Dr. Wiegand serves as Medical Director for Huther Doyle Chemical Dependency treatment program in Rochester, NY and as detoxification specialist for Syracuse Behavioral Health in Rochester, NY. Tim serves on the New York Society of Addiction Medicine (NYSAM) Board of Directors as the Communication Committee Chair and he was recently elected to the American College of Medical Toxicology Board of Directors to begin a 3 year term in October, 2015. He currently serves as the chair of the Addiction Medicine Section for the American College of Medical Toxicology and he recently organized a very successful Addiction Medicine Academy for ACMT prior to their main Annual Scientific Meeting in Clearwater, Florida in March, 2015. Dr. Wiegand has presented for the ASAM Review Course on Pharmacology & Toxicology, MRO and drug testing principles at previous Review Course conferences.

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this enduring material for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The ASAM CME Committee and Reviewers Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

None

 

 

Catherine Friedman, MD

Vice Chair

None

 

  

Noel Ilogu, MD, MRCP, DFASAM

None

 

 

Hebert L. Malinoff, MD, FACP, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

Indivior

BDSI

Honorarium

Honorarium

Speaker

Consultant/Speaker

 

The ASAM Review Course Program Planning Committee Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

 

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, INC

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

 

Stock Owned through IRA Rollover Account

Stock Owned through IRA Rollover Account

Stock Options

(Spouse)

 

Bonds in IRA

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Erin Zerbo, MD

None

 

 

 

The ASAM Review Course Faculty Member Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

Jeffrey DeVido, MD, MTS

Philip Morris

 

 

Altria

Ownership Interest

 

Ownership Interest

Equity Shareholder

 

Equity Shareholder

Paul H. Earley, MD, DFASAM

Alkermes

 

Georgia PHP, INC

 

Earley Counsultancy, LLC

 

DynamiCare Health, INC

Honoraria

 

Salary

 

 

Salary

 

 

 

Salary

Speaker

 

Medical Director

 

 

Principal

 

 

 

Speaker

James W. Finch, MD, DFASAM

Orexo Pharmaceuticals

 

Indivior Pharmaceuticals

Honoraria

 

 

Honoraria

Speaker

 

 

Speaker

Marc Fishman, MD, DFASAM

Alkermes

 

 

US WorldMeds

 

 

 

 

MediaRez

Salary

 

 

Salary

 

 

 

 

Research Funding

Consultant; Advisory Board

 

Consultant; Advisory Board; Principal Research Investigator

 

Principal Research Investigator

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, Inc

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

Stock Owned through IRA Rollover Account

Stock Owned through IRA

 

Rollover Account

Stock Options

(Spouse)

Bonds in IRA

Leslie Hayes, MD

None

 

 

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Richard Ries, MD, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Sharon Stancliff, MD

None

 

 

Timothy J. Wiegand, MD, FACMT, FAACT, FASAM

None

 

 

Erin Zerbo, MD

None

 

 

Key:

Complete
Failed
Available
Locked
Pain and Addiction
Pain and Addiction Webinar
Recorded 08/08/2017
Recorded 08/08/2017 This webinar was hosted on 8/8/2017 at 12:00 PM Eastern Time.
CME Quiz - Spotlight Webinar 1
3 Questions
3 Questions Complete the quiz to claim CME for Spotlight Webinar 1 - Pain and Addiction
CME Evaluation - Spotlight Webinar 1
15 Questions
15 Questions This is the CME Evaluation for Spotlight Webinar 1: Pain and Addiction
CME Certificate - Spotlight Webinar 1
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Claim CME Credit.
Psychiatric Co-morbidities
Psychiatric Co-morbidities Webinar
Recorded 08/10/2017
Recorded 08/10/2017 This webinar was hosted on 8/10/2017 at 12:00 PM Eastern Time.
CME Quiz - Spotlight Webinar 2
3 Questions
3 Questions Complete the quiz to claim CME for Spotlight Webinar 2 - Psychiatric Comorbidities.
CME Evaluation - Spotlight Webinar 2
15 Questions
15 Questions This is the CME Evaluation for Spotlight Webinar 2: Psychiatric Co-morbidities
CME Certificate - Spotlight Webinar 2
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Claim CME Credit.
Cannabis
Cannabis Webinar
Recorded 08/15/2017
Recorded 08/15/2017 This webinar was hosted on 8/15/2017 at 2:30 PM Eastern Time.
CME Quiz - Spotlight Webinar 3
3 Questions
3 Questions Complete the quiz to claim CME for Spotlight Webinar 3 - Cannabis
CME Evaluation - Spotlight Webinar 3
15 Questions
15 Questions This is the CME Evaluation for Spotlight Webinar 3: Cannabis
CME Certificate - Spotlight Webinar 3
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Claim CME Credit.
Tobacco
Tobacco Webinar
Recorded 08/17/2017
Recorded 08/17/2017 This webinar was hosted on 8/17/2017 at 12:00 PM Eastern Time.
CME Quiz - Spotlight Webinar 4
3 Questions
3 Questions Complete the quiz to claim CME for Spotlight Webinar 4 - Tobacco
CME Evaluation - Spotlight Webinar 4
15 Questions
15 Questions This is the CME Evaluation for Spotlight Webinar 4: Tobacco
CME Certificate - Spotlight Webinar 4
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Claim CME Credit.
Prevention and Public Health
Prevention and Public Health Webinar
Recorded 08/24/2017
Recorded 08/24/2017 This webinar was hosted on 8/24/2017 at 3:00 PM Eastern Time.
CME Quiz - Spotlight Webinar 5
3 Questions
3 Questions This is the CME Evaluation for Spotlight Webinar 5: Prevention and Public Health
CME Evaluation - Spotlight Webinar 5
15 Questions
15 Questions This is the CME Evaluation for Spotlight Webinar 5: Public Health and Prevention
CME Certificate - Spotlight Webinar 5
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Claim CME Credit.
Pharmacology and Toxicology
Pharmacology and Toxicology Webinar
Recorded 08/30/2017
Recorded 08/30/2017 This webinar was hosted on 8/30/2017 at 3:00 PM Eastern Time.
CME Quiz - Spotlight Webinar 6
3 Questions
3 Questions Complete the quiz to claim CME for Spotlight Webinar 6 - Pharmacology and Toxicology
CME Evaluation - Spotlight Webinar 6
15 Questions
15 Questions This is the CME Evaluation for Spotlight Webinar 6: Pharmacology and Toxicology
CME Certificate - Spotlight Webinar 6
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Claim CME Credit.